News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
272,345 Results
Type
Article (14837)
Company Profile (284)
Press Release (257224)
Multimedia
Podcasts (48)
Webinars (7)
Section
Business (80783)
Career Advice (399)
Deals (13370)
Drug Delivery (35)
Drug Development (50669)
Employer Resources (40)
FDA (5786)
Job Trends (5561)
News (146567)
Policy (10241)
Tag
Academia (958)
Accelerated approval (2)
Adcomms (12)
Allergies (52)
Alliances (22136)
ALS (64)
Alzheimer's disease (857)
Antibody-drug conjugate (ADC) (101)
Approvals (5814)
Artificial intelligence (128)
Autoimmune disease (18)
Automation (5)
Bankruptcy (105)
Best Places to Work (4647)
BIOSECURE Act (6)
Biosimilars (43)
Biotechnology (234)
Bladder cancer (58)
Brain cancer (20)
Breast cancer (156)
Cancer (1488)
Cardiovascular disease (118)
Career advice (336)
Career pathing (4)
CAR-T (117)
Cell therapy (337)
Cervical cancer (8)
Clinical research (41238)
Collaboration (548)
Compensation (258)
Complete response letters (13)
COVID-19 (1066)
CRISPR (42)
C-suite (169)
Cystic fibrosis (76)
Data (1533)
Denatured (11)
Depression (30)
Diabetes (140)
Diagnostics (1337)
Digital health (4)
Diversity (2)
Diversity, equity & inclusion (12)
Drug discovery (85)
Drug pricing (28)
Drug shortages (3)
Duchenne muscular dystrophy (90)
Earnings (30096)
Editorial (20)
Employer branding (6)
Employer resources (38)
Events (49043)
Executive appointments (473)
FDA (6492)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (506)
Gene editing (99)
Generative AI (10)
Gene therapy (261)
GLP-1 (374)
Government (1138)
Grass and pollen (2)
Guidances (22)
Healthcare (6742)
Huntington's disease (22)
IgA nephropathy (25)
Immunology and inflammation (93)
Indications (20)
Infectious disease (1131)
Inflammatory bowel disease (115)
Inflation Reduction Act (8)
Influenza (19)
Intellectual property (67)
Interviews (84)
IPO (7322)
IRA (11)
Job creations (1200)
Job search strategy (287)
Kidney cancer (7)
Labor market (6)
Layoffs (215)
Leadership (6)
Legal (1447)
Liver cancer (33)
Lung cancer (206)
Lymphoma (102)
Machine learning (3)
Management (9)
Manufacturing (140)
MASH (53)
Medical device (2680)
Medtech (2681)
Mergers & acquisitions (6382)
Metabolic disorders (392)
Multiple sclerosis (54)
NASH (13)
Neurodegenerative disease (68)
Neuropsychiatric disorders (25)
Neuroscience (1268)
NextGen: Class of 2025 (2095)
Non-profit (961)
Now hiring (21)
Obesity (194)
Opinion (114)
Ovarian cancer (63)
Pain (43)
Pancreatic cancer (56)
Parkinson's disease (122)
Partnered (8)
Patents (130)
Patient recruitment (80)
Peanut (35)
People (26066)
Pharmaceutical (48)
Pharmacy benefit managers (5)
Phase I (14555)
Phase II (19175)
Phase III (12161)
Pipeline (814)
Policy (45)
Postmarket research (857)
Preclinical (6154)
Press Release (30)
Prostate cancer (62)
Psychedelics (35)
Radiopharmaceuticals (213)
Rare diseases (294)
Real estate (1487)
Recruiting (16)
Regulatory (8747)
Reports (15)
Research institute (966)
Resumes & cover letters (61)
Rett syndrome (4)
RNA editing (5)
RSV (10)
Schizophrenia (60)
Series A (98)
Series B (64)
Service/supplier (1)
Sickle cell disease (40)
Special edition (11)
Spinal muscular atrophy (117)
Sponsored (13)
Startups (1997)
State (1)
Stomach cancer (4)
Supply chain (23)
Tariffs (9)
The Weekly (36)
Vaccines (221)
Venture capitalists (32)
Weight loss (111)
Women's health (15)
Worklife (5)
Date
Today (99)
Last 7 days (528)
Last 30 days (1535)
Last 365 days (19743)
2025 (6353)
2024 (20765)
2023 (22620)
2022 (27022)
2021 (28033)
2020 (23928)
2019 (16624)
2018 (12100)
2017 (13936)
2016 (12014)
2015 (14541)
2014 (10681)
2013 (7802)
2012 (7685)
2011 (7748)
2010 (7523)
Location
Africa (184)
Alabama (42)
Alaska (3)
Arizona (53)
Arkansas (5)
Asia (17607)
Australia (2994)
California (3901)
Canada (1147)
China (362)
Colorado (151)
Connecticut (153)
Delaware (102)
Europe (37814)
Florida (470)
Georgia (116)
Idaho (17)
Illinois (238)
India (10)
Indiana (95)
Iowa (2)
Japan (75)
Kansas (62)
Kentucky (5)
Louisiana (3)
Maine (11)
Maryland (476)
Massachusetts (3102)
Michigan (70)
Minnesota (145)
Mississippi (1)
Missouri (25)
Montana (14)
Nebraska (4)
Nevada (17)
New Hampshire (14)
New Jersey (972)
New Mexico (13)
New York (1055)
North Carolina (558)
North Dakota (5)
Northern California (1713)
Ohio (114)
Oklahoma (9)
Oregon (21)
Pennsylvania (801)
Puerto Rico (6)
Rhode Island (19)
South America (251)
South Carolina (4)
Southern California (1508)
Tennessee (27)
Texas (452)
United States (13437)
Utah (53)
Virginia (80)
Washington D.C. (30)
Washington State (354)
Wisconsin (15)
272,345 Results for "forge therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Tenovi and GenieMD Forge Transformative Partnership to Expand Access to Remote Care and Enhance Medication Adherence
March 3, 2025
·
3 min read
Press Releases
Affinia Therapeutics and Forge Biologics Announce AAV cGMP Manufacturing Partnership to Advance Affinia Therapeutics’ Pipeline of Next-Generation Gene Therapies to the Clinic
November 13, 2024
·
3 min read
Press Releases
Baird Medical Celebrates 2024 Breakthroughs and Accolades, Forging a New Era in Minimally Invasive MWA Technology
January 27, 2025
·
5 min read
Deals
Grifols completes sale of a 20% equity stake in SRAAS and forges strategic alliance with Haier Group
Grifols, a global healthcare company and leading manufacturer of plasma-derived medicines, announced it has completed the sale of a 20% equity stake in Shanghai RAAS to Haier Group Corporation and forged a strategic alliance with Haier Group.
June 18, 2024
·
7 min read
BioMidwest
Forge Biologics Announces Nine Presentations at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual Meeting
Forge Biologics Announces Nine Presentations at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual Meeting.
April 30, 2024
·
4 min read
Business
Champions Oncology and Medicines Discovery Catapult Forge Partnership to Accelerate Radiopharmaceutical Therapeutics Development
Champions Oncology, Inc., a leader in the development of advanced preclinical oncology solutions, has announced a strategic partnership with Medicines Discovery Catapult, enhancing their combined capabilities in the expanding field of radiopharmaceutical therapeutics.
June 4, 2024
·
3 min read
Press Releases
Radiology Partners and RADPAIR Forge Strategic Partnership Focused on Generative AI Solutions for Radiology
December 2, 2024
·
4 min read
Deals
Ajinomoto Co., Inc. to Acquire Forge Biologics for $620 Million1
Ajinomoto Co., Inc. and Forge Biologics, announced that they have entered into a definitive agreement by which Ajinomoto Co., will acquire Forge, a leading manufacturer of genetic medicines, in an all-cash deal for $620 million.
November 13, 2023
·
4 min read
Press Releases
3Aware and RQM+ Forge Partnership to Enhance MedTech Compliance and Innovation
October 28, 2024
·
3 min read
Business
Leveragen and 92Bio Forge Strategic Alliance to Advance Therapeutics Using Novel Single Domain Antibody Platform
Leveragen, Inc. announced today that it has entered into a multi-target commercial license agreement with 92Bio, Inc., a biotech firm focused on the development of therapeutic antibodies.
May 28, 2024
·
3 min read
1 of 27,235
Next
